Sato, R.; Imamura, K.; Sakata, S.; Ikeda, T.; Horio, Y.; Iyama, S.; Akaike, K.; Hamada, S.; Jodai, T.; Nakashima, K.;
et al. Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies. J. Clin. Med. 2019, 8, 762.
https://doi.org/10.3390/jcm8060762
AMA Style
Sato R, Imamura K, Sakata S, Ikeda T, Horio Y, Iyama S, Akaike K, Hamada S, Jodai T, Nakashima K,
et al. Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies. Journal of Clinical Medicine. 2019; 8(6):762.
https://doi.org/10.3390/jcm8060762
Chicago/Turabian Style
Sato, Ryo, Kosuke Imamura, Shinya Sakata, Tokunori Ikeda, Yuko Horio, Shinji Iyama, Kimitaka Akaike, Shohei Hamada, Takayuki Jodai, Kei Nakashima,
and et al. 2019. "Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies" Journal of Clinical Medicine 8, no. 6: 762.
https://doi.org/10.3390/jcm8060762
APA Style
Sato, R., Imamura, K., Sakata, S., Ikeda, T., Horio, Y., Iyama, S., Akaike, K., Hamada, S., Jodai, T., Nakashima, K., Ishizuka, S., Sato, N., Saruwatari, K., Saeki, S., Tomita, Y., & Sakagami, T.
(2019). Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies. Journal of Clinical Medicine, 8(6), 762.
https://doi.org/10.3390/jcm8060762
